Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0039 | 1 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.2064 | 0.2064 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.3178 | 0.2258 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Echinococcus multilocularis | multidrug resistance associated protein 7 | 0.0018 | 0.3253 | 0.3253 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Leishmania major | ATP-binding cassette protein subfamily C, member 6, putative | 0.0018 | 0.3253 | 0.1497 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.2064 | 0.2064 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1497 |
Giardia lamblia | MRP-like ABC transporter | 0.0018 | 0.3253 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | multidrug resistance protein E, putative | 0.0018 | 0.3253 | 0.2407 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.3253 | 0.2343 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.0018 | 0.3253 | 0.2407 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1497 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Echinococcus granulosus | multidrug resistance associated protein 4 | 0.0011 | 0.1114 | 0.1114 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6974 | 0.6595 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0039 | 1 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1497 |
Leishmania major | ATP-binding cassette protein subfamily C, member 5, putative | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1497 |
Leishmania major | ABC-thiol transporter | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma brucei | trans-sialidase | 0.003 | 0.6974 | 0.5515 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0039 | 1 | 1 |
Echinococcus granulosus | multidrug resistance associated protein 1 | 0.0018 | 0.3253 | 0.3253 |
Leishmania major | ATP-binding cassette protein subfamily C, member 1, putative | 0.0018 | 0.3253 | 0.1497 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0039 | 1 | 1 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Leishmania major | ATP-binding cassette protein subfamily C, member 2, putative | 0.0018 | 0.3253 | 0.1497 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6974 | 0.6595 |
Loa Loa (eye worm) | ABC transporter transmembrane region family protein | 0.0018 | 0.3253 | 0.2343 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2064 | 0.2064 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.2064 | 0.2064 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0039 | 1 | 1 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0039 | 1 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0014 | 0.2064 | 0.5 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.0018 | 0.3253 | 1 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0014 | 0.2064 | 0.0994 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6974 | 0.6595 |
Entamoeba histolytica | ABC transporter, putative | 0.0018 | 0.3253 | 0.1497 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2064 | 0.2064 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2064 | 0.2064 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2064 | 0.2064 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1497 |
Echinococcus multilocularis | multidrug resistance associated protein 4 | 0.0011 | 0.1114 | 0.1114 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2064 | 0.2064 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.2064 | 0.0994 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0039 | 1 | 1 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.2064 | 0.0994 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.0018 | 0.3253 | 0.1497 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0039 | 1 | 1 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.3253 | 0.2343 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Entamoeba histolytica | multidrug resistance protein, putative | 0.0018 | 0.3253 | 0.1497 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0039 | 1 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0039 | 1 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0014 | 0.199 | 0.199 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.2064 | 0.2064 |
Leishmania major | pentamidine resistance protein 1 | 0.0018 | 0.3253 | 0.1497 |
Leishmania major | p-glycoprotein e | 0.0018 | 0.3253 | 0.1497 |
Giardia lamblia | ABC transporter, putative | 0.0018 | 0.3253 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0014 | 0.2064 | 0.2064 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0014 | 0.2064 | 0.5 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.0018 | 0.3253 | 0.2407 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.199 | 0.091 |
Brugia malayi | multidrug resistance related protein 1 | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0039 | 1 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | taga, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0014 | 0.199 | 0.199 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0039 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Echinococcus multilocularis | multidrug resistance associated protein 1 | 0.0018 | 0.3253 | 0.3253 |
Echinococcus granulosus | multidrug resistance associated protein 7 | 0.0018 | 0.3253 | 0.3253 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2064 | 0.2064 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0039 | 1 | 1 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0039 | 1 | 1 |
Onchocerca volvulus | 0.0014 | 0.2064 | 0.5 | |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Brugia malayi | ABC transporter transmembrane region family protein | 0.0018 | 0.3253 | 0.1497 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2064 | 0.2064 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0039 | 1 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.0018 | 0.3253 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0014 | 0.2064 | 0.0994 |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.0039 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | > 64 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.